Nanobody stabilization of G protein-coupled receptor conformational states

Current Opinion in Structural Biology

Volumn 21, Issue 4, 2011, Pages 567-572

  Steyaert, Jan ^a   Kobilka, Brian K ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CHAPERONE; G PROTEIN COUPLED RECEPTOR; ISOPROTEIN; PEPTIDE FRAGMENT; RHODOPSIN;

CRYSTALLIZATION; CRYSTALLOGRAPHY; ENZYME ACTIVATION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CRYSTALLOGRAPHY, X-RAY; HUMANS; IMMUNOGLOBULIN FRAGMENTS; PROTEIN CONFORMATION; PROTEIN STABILITY; RECEPTORS, G-PROTEIN-COUPLED; SINGLE-CHAIN ANTIBODIES;

CAMELIDAE;

EID: 80052083563     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2011.06.011     Document Type: Review

References (49)

1. Tesmer J.J.G. The quest to understand heterotrimeric G protein signaling. Nat Struct Mol Biol 2010, 17:650-652.
2. Kovacs J.J., Hara M.R., Davenport C.L., Kim J., Lefkowitz R.J. Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. Dev Cell 2009, 17:443-458.
3. Whalen E.J., Rajagopal S., Lefkowitz R.J. Therapeutic potential of β-arrestin- and G protein-biased agonists. Trends Mol Med 2011, 17:126-139.
4. Rajagopal S., Rajagopal K., Lefkowitz R.J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 2010, 9:373-386.
5. Deupi X., Kobilka B.K. Energy landscapes as a tool to integrate GPCR structure, dynamics, and function. Physiology 2010, 25:293-303.
6. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Trong I.L., Teller D.C., Okada T., Stenkamp R.E., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000, 289:739-745.
7. Li J., Edwards P., Burghammer M., Villa C., Schertler G.F.X. Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol 2004, 343:1409-1438.
8. Rasmussen S.G.F., Choi H.-J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., Burghammer M., Ratnala V.R.P., Sanishvili R., Fischetti R.F. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007, 450:383-387.
9. Rosenbaum D.M., Cherezov V, Hanson M.A., Rasmussen S.G.F., Thian F.S., Kobilka T.S., Choi H.-J., Yao X.-J., Weis W.I., Stevens R.C., et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007, 318:1266-1273.
10. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G.F., Thian F.S., Kobilka T.S., Choi H.-J., Kuhn P., Weis W.I., Kobilka B.K., et al. High-resolution crystal structure of an engineered human 2-adrenergic G protein coupled receptor. Science 2007, 318:1258-1265.
11. Warne T., Serrano-Vega M.J., Baker J.G., Moukhametzianov R., Edwards P.C., Henderson R., Leslie A.G.W., Tate C.G., Schertler G.F.X. Structure of a β1-adrenergic G-protein-coupled receptor. Nature 2008, 454:486-491.
12. Chien E.Y.T., Liu W., Zhao Q., Katritch V., Won Han G., Hanson M.A., Shi L., Newman A.H., Javitch J.A., Cherezov V., et al. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 2010, 330:1091-1095.
13. Wu B., Chien E.Y.T., Mol C.D., Fenalti G., Liu W., Katritch V., Abagyan R., Brooun A., Wells P., Bi F.C., et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010, 1066-1071.
14. Jaakola V.-P., Griffith M.T., Hanson M.A., Cherezov V., Chien E.Y.T., Lane J.R., IJzerman A.P., Stevens R.C. The 2.6 Angstrom crystal structure of a human a2a adenosine receptor bound to an antagonist. Science 2008, 322:1211-1217.
15. Shimamura T., Shiroishi M., Weyand S., Tsujimoto H., Winter G., Katritch V., Abagyan R., Cherezov V., Liu W., Han G.W., et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 2011, 10.1038/nature10236.
16. Park J.H., Scheerer P., Hofmann K.P., Choe H.-W., Ernst O.P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 2008, 454:183-187.
17. Hofmann KP Signalling states of photoactivated rhodopsin. Novartis Found Symp 1999, 224:158-175. (discussion 175-180).
18. Vogel R., Siebert F. Conformations of the active and inactive states of opsin. J Biol Chem 2001, 276:38487-38493.
19. Arnis S., Fahmy K., Hofmann K.P., Sakmar T.P. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J Biol Chem 1994, 269:23879-23881.
20. Scheerer P., Park J.H., Hildebrand P.W., Kim Y.J., Krauss N., Choe H.-W., Hofmann K.P., Ernst O.P. Crystal structure of opsin in its G-protein-interacting conformation. Nature 2008, 455:497-502.
21. Choe H.-W., Kim Y.J., Park J.H., Morizumi T., Pai E.F., Krauß N., Hofmann K.P., Scheerer P., Ernst O.P. Crystal structure of metarhodopsin II. Nature 2011, 1-6.
22. Standfuss J., Edwards P.C., D'Antona A., Fransen M., Xie G., Oprian D.D., Schertler G.F.X. The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature 2010, 45:656-660.
23. Rosenbaum D.M., Zhang C., Lyons J.A., Holl R., Aragao D., Arlow D.H., Rasmussen S.G.F., Choi H.-J., DeVree B.T., Sunahara R.K., et al. Structure and function of an irreversible agonist-β2 adrenoceptor complex. Nature 2011, 469:236-240.
24. Warne T., Moukhametzianov R., Baker J.G., Nehmé R., Edwards P.C., Leslie A.G.W., Schertler G.F.X., Tate C.G. The structural basis for agonist and partial agonist action on a β1-adrenergic receptor. Nature 2011, 469:241-244.
25. Whorton M.R., Rasmussen S.G.F., Devree B.T., Deupi X., Jie X., Ve G., Sunahara R.K., Kobilka B.K. The effect of ligand efficacy on the formation and stability of a GPCR·G protein complex. Proc Natl Acad Sci U S A 2009, 106:1-6.
26. Ghanouni P., Schambye H., Seifert R. The effect of pH on β2 adrenoceptor function. J Biol Chem 2000, 275:3121-3127.
27. Tate C.G., Schertler G.F.X. Engineering G protein-coupled receptors to facilitate their structure determination. Curr Opin Struct Biol 2009, 19:386-395.
28. Parnot C., Miserey-Lenkei S., Bardin S., Corvol P., Clauser E. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol Metab 2002, 13:336-343.
29. Gether U., Seifert J. Structural instability of a constitutively active G protein-coupled receptor. J Biol Chem 1997, 272:2587-2590.
30. Delean A., Stadel J.M., Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J Biol Chem 1980, 255:7108-7117.
31. Whorton M.R., Bokoch M.P., Rasmussen S.G.F., Huang B., Zare R.N., Kobilka B.K., Sunahara R.K. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci U S A 2007, 104:7682-7687.
32. Gurevich V., Pals-Rylaarsdam R. Agonist-receptor-arrestin, an alternative ternary complex with high agonist affinity. J Biol Chem 1997, 272:28849-28852.
33. Martini L., Hastrup H., Holst B., Fraile-Ramos A., Marsh M., Schwartz T.W. NK1 receptor fused to beta-arrestin displays a single-component, high-affinity molecular phenotype. Mol Pharmacol 2002, 62:30-37.
34. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E.B., Bendahman N., Hamers R. Naturally occurring antibodies devoid of light chains. Nature 1993, 363:446-448.
35. Muyldermans S., Cambillau C., Wyns L. Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. Trends Biochem Sci 2001, 26:230-235.
36. Frenken L.G.J., van der Linden R.H.J., Hermans P.W.J.J., Ruuls R.C., De Geus B., Verrips C.T. Isolation of antigen specific Llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol 2000, 78:11-21.
37. Muyldermans S. Single domain camel antibodies: current status. J Biotechnol 2001, 74:277-302.
38. Lauwereys M., Arbabi G.M., Desmyter A., Kinne J., Holzer W., De Genst E., Wyns L., Muyldermans S. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J 1998, 17:3512-3520.
39. De Genst E., Silence K., Decanniere K., Conrath K., Loris R., Kinne J., Muyldermans S., Wyns L. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc Natl Acad Sci U S A 2006, 103:4586-4591.
40. Domanska K., Vanderhaegen S., Srinivasan V., Pardon E., Dupeux F., Marquez J.A., Giorgetti S., Stoppini M., Wyns L., Bellotti V., et al. Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic β2-microglobulin variant. Proc Natl Acad Sci U S A 2011, 108:1314-1319.
41. Korotkov K.V., Pardon E., Steyaert J., Hol W.G.J. Crystal structure of the N-terminal domain of the secretin GspD from ETEC determined with the assistance of a nanobody. Structure 2009, 17:255-265. 10.1016/j.str.2008.11.011.
42. Loris R., Marianovsky I., Lah J., Laeremans T., Engelberg-Kulka H., Glaser G., Muyldermans S., Wyns L. Crystal structure of the intrinsically flexible addiction antidote MazE. J Biol Chem 2003, 278:28252-28257.
43. Wu M., Park Y.-J., Pardon E., Turley S., Hayhurst A., Deng J., Steyaert J., Hol W.G.J. Structures of a key interaction protein from the Trypanosoma brucei editosome in complex with single domain antibodies. J Struct Biol 2011, 174:124-136.
44. De Genst E.J., Guilliams T., Wellens J., O'Day E.M., Waudby C.A., Meehan S., Dumoulin M., Hsu S-TD, Cremades N., Verschueren K.H.G., et al. Structure and properties of a complex of alpha-synuclein and a single-domain camelid antibody. J Mol Biol 2010, 402:326-343.
45. Rasmussen S.G.F., Choi H.J., Fung J.J., Pardon E., Casarosa P., Chae P.S., DeVree B.T., Rosenbaum D.M., Thian F.S., Kobilka T.S., et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor. Nature 2011, 469:175-180.
46. Conrath K.E., Lauwereys M., Galleni M., Matagne A., Frere J.M., Kinne J., Wyns L., Muyldermans S. Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob Agents Chemother 2001, 45:2807-2812.
47. Caffrey M. Crystallizing membrane proteins for structure determination: use of lipidic mesophases. Annu Rev Biophys 2009, 38:29-51.
48. Sanishvili R., Nagarajan V., Yoder D., Becker M., Xu S., Corcoran S., Akey D.L., Smith J.L., Fischetti R.F. A 7μm mini-beam improves diffraction data from small or imperfect crystals of macromolecules. Acta Crystallogr D: Biol Crystallogr 2008, 64:425-435.
49. Xu F., Wu H., Katritch V., Han G.W., Jacobson K.A., Gao Z.-G., Cherezov V., Stevens R.C. Structure of an agonist-bound human A2A adenosine receptor. Science 2011, 322:322-327.